GlassScriptPhysician profile
Amir Lebaschi
NPI 1538690854
$6,108.75
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,138 · 2024: $3,726 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,783 · Food and Beverage: $2,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,783.39 |
| Food and Beverage | $2,325.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,956.76 | 2023-2025 | Mako, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $1,468.14 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $809.98 | 2024 | Iovera |
| Zimmer Biomet Holdings, INC. | $280.16 | 2023-2024 | Tapestry, Arthroscopy Instrument Systems, Accufill |
| Pinnacle, INC | $146.45 | 2023-2024 | |
| Smith+Nephew, INC. | $141.39 | 2024 | Q-Fix |
| Depuy Synthes Sales INC. | $110.25 | 2023-2025 | Inhance |
| Kinamed, INC. | $84.00 | 2024 | |
| Bioventus LLC | $47.51 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Abbvie INC. | $23.94 | 2024 | |
| Solventum Corporation | $23.02 | 2025 | Activ.A.C. |
| Kairos Surgical INC | $17.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Lebaschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.